
Moderna gets the ultimate Wall Street validation: It's being added to the S&P 500
CNN
Moderna, the biotech that became a household name with its Covid-19 vaccine, is getting the ultimate Wall Street validation: It's being added to the S&P 500 index.
S&P made the announcement late Thursday, and shares of Moderna (MRNA) surged 10% Friday morning on the news. The stock is now up nearly 175% this year, giving Moderna a market valuation of more than $100 billion. Moderna's addition to the S&P 500 means that the scores of passively managed mutual funds and exchange-traded funds that mirror the S&P 500 will need to add the company's stock to their portfolios. That's a key reason that the stock was popping Friday.More Related News

The House Judiciary Committee is demanding interviews with four current and former Department of Justice officials who were involved in subpoenaing phone records for several members of Congress around the January 6, 2021, Capitol attack, the day before Republicans interview former special counsel Jack Smith.












